As part of the proposed free trade agreement with Britain, India is looking at expanding market access for its pharmaceutical items in the UK, an official said on Friday.
The official added that a leaked chapter of the agreement on intellectual property (IP), which has been circulated on several portals, has been altered from its original form by the UK.
“The best part in the proposed agreement is that both sides have highlighted their red lines and sensitivities. Ever-greening and touching manufacturing of generic medicines is completely non-negotiable,” the official added.
In a trade agreement with the UAE, India has already increased market access for the domestic pharmaceutical industry.